Targeting DNA repair pathways to overcome cancer drug resistance

Robert C.A.M. van Waardenburg, Eddy S. Yang

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations
Original languageEnglish
Pages (from-to)837-841
Number of pages5
JournalCancer Drug Resistance
Volume4
Issue number4
DOIs
StatePublished - 2021

Bibliographical note

Funding Information:
van Waardenburg RCAM in part funded by American Cancer Society UAB ACS-IRG Junior Faculty Development Grant (ACS-IRG-60-001-53), Department of Defense OCRP pilot award W81XWH-15-1-0198, and the National Institutes of Health Cancer Center Core Support Grant (P30CA013148) and National Institutes of Health - National Institute of Disorders and Stroke (1R21NS116312-01A1).

Funding

van Waardenburg RCAM in part funded by American Cancer Society UAB ACS-IRG Junior Faculty Development Grant (ACS-IRG-60-001-53), Department of Defense OCRP pilot award W81XWH-15-1-0198, and the National Institutes of Health Cancer Center Core Support Grant (P30CA013148) and National Institutes of Health - National Institute of Disorders and Stroke (1R21NS116312-01A1).

FundersFunder number
Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke Council1R21NS116312-01A1
National Institutes of Health (NIH)P30CA013148
National Institutes of Health (NIH)
U.S. Department of DefenseW81XWH-15-1-0198
U.S. Department of Defense
American Cancer Society-Michigan Cancer Research FundACS-IRG-60-001-53
American Cancer Society-Michigan Cancer Research Fund

    ASJC Scopus subject areas

    • Cancer Research
    • Pharmacology (medical)

    Fingerprint

    Dive into the research topics of 'Targeting DNA repair pathways to overcome cancer drug resistance'. Together they form a unique fingerprint.

    Cite this